Report overview
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient?s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
This report aims to provide a comprehensive presentation of the global market for Cancer Therapeutics and Supportive Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Therapeutics and Supportive Care Drugs. This report contains market size and forecasts of Cancer Therapeutics and Supportive Care Drugs in global, including the following market information:
Global Cancer Therapeutics and Supportive Care Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Therapeutics and Supportive Care Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cancer Therapeutics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Therapeutics and Supportive Care Drugs include Abbott Laboratories, AstraZeneca plc, Astellas Pharma, Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Novartis, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Therapeutics and Supportive Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Therapeutics and Supportive Care Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, by Type, 2022 (%)
Cancer Therapeutics
Supportive Care Drugs
Global Cancer Therapeutics and Supportive Care Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacies
Global Cancer Therapeutics and Supportive Care Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Therapeutics and Supportive Care Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Therapeutics and Supportive Care Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Therapeutics and Supportive Care Drugs, market overview.
Chapter 2: Global Cancer Therapeutics and Supportive Care Drugs market size in revenue.
Chapter 3: Detailed analysis of Cancer Therapeutics and Supportive Care Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Therapeutics and Supportive Care Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
